We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 11-20 of 500

Federal court enjoins enforcement of Massachusetts opioid regulations

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • July 17 2014

A federal court in Massachusetts has issued a preliminary injunction in a challenge to the Commonwealth's regulation of a specific opioid

New infringement lawsuit filed to protect BRCA1 and BRCA2 patents

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 26 2014

Myriad Genetics has brought a new infringement lawsuit against a company offering a next-generation sequencing test that analyzes the BRCA1 and BRCA2

News bytes

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 26 2014

The U.S. Patent and Trademark Office (USPTO) requests nominations for open three-year positions on the Patent Public Advisory Committee and Trademark

USPTO proposes changes to patent term adjustment

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 26 2014

In response to the Federal Circuit Court of Appeals ruling in Novartis AG v. Lee, summarized in Issue 71 of this Bulletin, the U.S. Patent and

Supplier sentenced for illegal sales of non-approved drugs

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 26 2014

According to the U.S. Department of Justice, a federal court in Virginia has sentenced a U.S. citizen, who owned and operated several companies in

FDA accepts 23andMe 510(k) application for single-condition health report

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 26 2014

The U.S. Food and Drug Administration (FDA) has reportedly accepted for review 23andMe's submission for the premarket approval of a new medical

Democratic lawmakers ask NIH to disclose demographic data for clinical trials

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 26 2014

Led by Reps. Louise slaughter (D-N.Y.), Rosa DeLauro (D-Conn.) and Lois Capps (D-Calif.), 22 U.S. House Democrats have written to National Institutes

Considering end-user interests in patent-law reforms

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 26 2014

Seton Hall University School of Law Professor Gaia Bernstein analyzes the rising role of end users in the patent-litigation landscape and argues that

FDA inspection finds CGMP violations at Bangalore facility

  • Shook Hardy & Bacon LLP
  • -
  • India, USA
  • -
  • June 26 2014

The U.S. Food and Drug Administration (FDA) has issued a warning letter to the president and CEO of Apotex, Inc., claiming that the agency's

Biotech employment gains make up for pharma losses

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 26 2014

According to new EP Vantage research, while employment in those companies characterized as "Big Pharma" decreased slightly in the period 2003-2013